It is a novel class of small molecules with the dual mechanism as estrogen receptor antagonist ( and degrader SERDs are a type of hormonal therapy used in the treatment of ER positive/HER 2 negative locally advanced or metastatic breast cancer They can be employed as monotherapy or in combination with other drugs SERDs are considered one of the most revolutionary cancer therapies due to their superior clinical profile and ease of administration impacting the quality of life of breast cancer patients positively

1.Market Segmentation

2.Introduction

3.Executive Summary

4.Global SERD Therapeutics Market Legal Requirements and Frameworks

6.Global SERD Therapeutics Market Hotspot & Opportunities

7.Global SERD Therapeutics Market Outlook, 2019-2030F